Proprioceptive Neuromuscular Facilitation vs Conventional Therapy With Ultrasound-Guided Corticosteroid Injections for Subacromial Bursitis
CompletedPhase 1, Phase 2NCT07508969
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to evaluate the effectiveness of a combined treatment approach for people with chronic shoulder pain caused by subacromial bursitis. Subacromial bursitis is a common condition that can cause pain, stiffness, and reduced ability to move the shoulder. These symptoms often interfere with daily activities such as dressing, lifting objects, or reaching overhead, and may negatively affect quality of life. In current clinical practice, corticosteroid injections are frequently used to reduce inflammation and relieve pain, especially in patients with persistent symptoms. Physiotherapy is also an essential part of treatment, helping to restore movement, strength, and function. However, it is not yet clear which type of rehabilitation program provides the best results when combined with injections. In this study, all participants receive three ultrasound-guided corticosteroid injections administered once per week. Ultrasound guidance allows the physician to accurately deliver the medication into the affected area, improving safety and precision. After the injections, participants are randomly assigned to one of two rehabilitation programs. One group performs a program based on Proprioceptive Neuromuscular Facilitation (PNF), a technique that uses specific movement patterns to improve muscle coordination, flexibility, and strength. The other group receives conventional physiotherapy, including standard exercises aimed at improving shoulder mobility and function. Participants are evaluated over time to assess changes in pain, daily function, quality of life, and shoulder movement, with follow-up lasting up to six months. The purpose of this study is to determine whether one rehabilitation approach is more effective than the other when combined with corticosteroid injections. The study aims to answer the following question: Does a rehabilitation program based on Proprioceptive Neuromuscular Facilitation (PNF), combined with ultrasound-guided corticosteroid injecti…
Study details
- Official title
- Efficacy of a Proprioceptive Neuromuscular Facilitation Versus Conventional Physical Therapy, Combined With Ultrasound-guided Corticosteroids Injections, in Subacromial Bursitis: a Randomized Controlled Trial
- Conditions
- Subacromial Bursitis of the Shoulder
- Chronic Shoulder Pain
- Interventions
- Drug: Ultrasound-Guided Corticosteroid Injections plus PNF
- Drug: Ultrasound-Guided Corticosteroid Injections plus Conventional Physiotherapy
- Sponsor
- University of Catanzaro
- Start date
- 2025-01-01
- Primary completion
- 2025-03-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Italy
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults aged ≥ 18 years * Diagnosis of chronic shoulder pain (duration ≥ 3 months) * Pain intensity ≥ 4 on the Numeric Rating Scale (NRS) * Body Mass Index (BMI) \< 30 kg/m² * Ability to understand and provide written informed consent Exclusion Criteria: * Severe cognitive impairment (Mini-Mental State Examination \< 24) or inability to provide informed consent * Severe cardiovascular or cerebrovascular diseases * History of neurological or psychiatric disorders * Active oncological disease * Rheumatoid arthritis * Previous shoulder arthroplasty * Severe osteoporosis * Use of oral analgesics, intra-articular injections, physiotherapy, or physical therapies within 15 days prior to enrollment;
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07508969